The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome: Results From the FINGER Brugada Syndrome Registry
Open accessAbstract
BACKGROUND: Brugada syndrome is characterized by ST-segment elevation in the right precordial leads and an increased risk of sudden cardiac death (SCD). Fundamental questions remain on the best strategy for assessing the real disease-associated arrhythmic risk, especially in asymptomatic patients. The aim of the present study was to evaluate the prognosis and risk factors of SCD in Brugada syndrome patients in the FINGER (France, Italy, Netherlands, Germany) Brugada syndrome registry. METHODS AND RESULTS: Patients were recruited in 11 tertiary centers in 4 European countries. Inclusion criteria consisted of a type 1 ECG present either at baseline or after drug challenge, after exclusion of diseases that mimic Brugada syndrome. The registry included 1029 consecutive individuals (745 men; 72%) with a median age of 45 (35 to 55) years. Diagnosis was based on (1) aborted SCD (6%); (2) syncope, otherwise unexplained (30%); and (3) asymptomatic patients (64%). During a median follow-up of 31.9 (14 to 54.4) months, 51 cardiac events (5%) occurred (44 patients experienced appropriate implantable cardioverter-defibrillator shocks, and 7 died suddenly). The cardiac event rate per year was 7.7% in patients with aborted SCD, 1.9% in patients with syncope, and 0.5% in asymptomatic patients. Symptoms and spontaneous type 1 ECG were predictors of arrhythmic events, whereas gender, familial history of SCD, inducibility of ventricular tachyarrhythmias during electrophysiological study, and the presence of an SCN5A mutation were not predictive of arrhythmic events. CONCLUSIONS: In the largest series of Brugada syndrome patients thus far, event rates in asymptomatic patients were low. Inducibility of ventricular tachyarrhythmia and family history of SCD were not predictors of cardiac events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In general, a history of syncope in patients with structural heart disease or inheritable arrhythmia syndromes is associated with a two- to four-fold increased risk of death, 348,350-353 but varies between specific conditions. 354-356”
From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [353]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the largest registry (1029 patients), the incidence of arrhythmic events (sustained VT or VF, appropriate ICD therapy, or sudden death) in patients with Brugada syndrome was 7.7% per year in those with a history of sudden cardiac arrest, 1.9% per year with syncope, and 0.5% per year in asymptomatic patients. 353”
From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [353]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ahistory of syncope may increase the risk of arrhythmic events up to two- to three-fold compared with that in asymptomatic patients.”
From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [353]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brugada, P., & Brugada, J. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90253-j · Cited by 3,344
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation
Chen, Q., Kirsch, G. E., Zhang, D., Brugada, R., Brugada, J., Brugada, P., Potenza, D. R., Moya‐Mitjans, À., Borggrefe, M., BREITHARDT, G. E., et al. (1998) · Nature · doi:10.1038/32675 · Cited by 1,823
Self-citationNatural History of Brugada Syndrome
Priori, S. G., Napolitano, C., Gasparini, M., Pappone, C., Bella, P. E. D., Giordano, U., Bloise, R., Giustetto, C., Nardis, R. D., Grillo, M., et al. (2002) · Circulation · doi:10.1161/hc1102.105288 · Cited by 1,030
Self-citationAntzelevitch, C., Pollevick, G. D., Cordeiro, J. M., Casis, O., Sanguinetti, M. C., Aizawa, Y., Guerchicoff, A., Pfeiffer, R., Oliva, A., Wollnik, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.668392 · Cited by 933
Self-citationBrugada, J., Brugada, R., Antzelevitch, C. N., Towbin, J. A., Nademanee, K., & Brugada, P. (2002) · Circulation · doi:10.1161/hc0102.101354 · Cited by 624
Brugada Syndrome: Report of the Second Consensus Conference
(2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.01.005 · Cited by 609
Self-citationBrugada, J., Brugada, R., & Brugada, P. (2003) · Circulation · doi:10.1161/01.cir.0000104568.13957.4f · Cited by 546
Watanabe, H., Koopmann, T., Scouarnec, S. L., Yang, T., Ingram, C. R., Schott, J., Demolombe, S., Probst, V., Anselme, F., Escande, D., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33891 · Cited by 507
Self-citationEfficacy of Quinidine in High-Risk Patients With Brugada Syndrome
Belhassen, B., Glick, A., & Viskin, S. (2004) · Circulation · doi:10.1161/01.cir.0000143159.30585.90 · Cited by 490
Long-Term Prognosis of Individuals With Right Precordial ST-Segment–Elevation Brugada Syndrome
Eckardt, L., Probst, V., Smits, J. P. P., Schulze‐Bahr, E., Wolpert, C., Schimpf, R., Wichter, T., Boisseau, P., Heinecke, A., BREITHARDT, G. E., et al. (2005) · Circulation · doi:10.1161/01.cir.0000153267.21278.8d · Cited by 447
Self-citationOutcome After Implantation of a Cardioverter-Defibrillator in Patients With Brugada Syndrome
Sacher, F., Probst, V., Maury, P., Babuty, D., Mansourati, J., Komatsu, Y., Marquié, C., Rosa, A., Diallo, A., Cassagneau, R., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001941 · Cited by 442
Self-citationLondon, B., Michalec, M., Mehdi, H., Zhu, X., Kerchner, L., Sanyal, S., Viswanathan, P. C., Pfahnl, A. E., Shang, L. L., Madhusudanan, M., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.703330 · Cited by 437
The Brugada Syndrome: Ionic Basis and Arrhythmia Mechanisms
Antzelevitch, C. (2001) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2001.00268.x · Cited by 415
Smits, J. P. P., Eckardt, L., Probst, V., Bezzina, C. R., Schott, J., Remme, C. A., Haverkamp, W., Breithardt, G., Escande, D., Schulze‐Bahr, E., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01962-9 · Cited by 385
Self-citationMeregalli, P. G., Wilde, A. A. M., & Tan, H. L. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.03.005 · Cited by 373
Self-citationKyndt, F., Probst, V., Potet, F., Demolombe, S., Chevallier, J.-C., Baró, I., Moisan, J., Boisseau, P., Schott, J., Escande, D., et al. (2001) · Circulation · doi:10.1161/hc5001.100834 · Cited by 363
Self-citationRisk Stratification of Individuals with the Brugada Electrocardiogram: A Meta‐Analysis
Gehi, A. K., Duong, T. D., Metz, L. D., Gomes, J. A., & Mehta, D. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00455.x · Cited by 332
Proposed Diagnostic Criteria for the Brugada Syndrome
Wilde, A. A. M. (2002) · European Heart Journal · doi:10.1053/euhj.2002.3382 · Cited by 330
Self-citationOutcome After Implantation of a Cardioverter-Defibrillator in Patients With Brugada Syndrome
Sacher, F., Probst, V., Iesaka, Y., Jacon, P., Laborderie, J., Mizon-Gérard, F., Mabo, P., Reuter, S., LAMAISON, D., Takahashi, Y., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.628537 · Cited by 290
Self-citationHydroquinidine therapy in Brugada syndrome
Hermida, J., Denjoy, I., Clerc, J., Extramiana, F., JARRY, G., Milliez, P., Guicheney, P., Fusco, S. A. D., Rey, J.-L., CAUCHEMEZ, B., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.12.046 · Cited by 267
Clinical and Molecular Heterogeneity in the Brugada Syndrome
Weiss, R., Barmada, M. M., Nguyen, T., Seibel, J. S., Cavlovich, D., Kornblit, C. A., Angelilli, A., Villanueva, F. S., McNamara, D. M., & London, B. (2002) · Circulation · doi:10.1161/hc0602.103618 · Cited by 246
Sarkozy, A., Boussy, T., Kourgiannides, G., Chierchia, G., Richter, S., Potter, T. D., Geelen, P., Wellens, F., Spreeuwenberg, M. D., & Brugada, P. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl450 · Cited by 230
Brugada, P., Brugada, R., & Brugada, J. (2005) · Circulation · doi:10.1161/circulationaha.104.485326 · Cited by 204
Watanabe, H., Koopmann, T. T., Scouarnec, S. L., Yang, T., Ingram, C. R., Schott, J.-J., Demolombe, S., Probst, V., Anselme, F., Escande, D., et al. (2008) · Pure Amsterdam UMC · doi:10.1172/jc133891 · Cited by 196
Self-citationVeltmann, C., Schimpf, R., Echternach, C., Eckardt, L., Kuschyk, J., Streitner, F., SPEHL, S., Borggrefe, M. M., & Wolpert, C. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl205 · Cited by 192
Self-citationPaul, M., Gerss, J., Schulze‐Bahr, E., Wichter, T., Vahlhaus, C., Wilde, A. A. M., Breithardt, G., & Eckardt, L. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm116 · Cited by 182
Self-citationPrognostic Value of Electrophysiologic Investigations in Brugada Syndrome
Brugada, P., Geelen, P., Brugada, R., Mont, L., & Brugada, J. (2001) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2001.01004.x · Cited by 154
Giustetto, C., Drago, S., Demarchi, P. G., Dalmasso, P., Bianchi, F., Masi, A. A., Carvalho, P., Occhetta, E., Rossetti, G., Riccardi, R., et al. (2008) · EP Europace · doi:10.1093/europace/eup006 · Cited by 129
Self-citationBenito, B., Brugada, R., Brugada, J., & Brugada, P. (2008) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2008.05.002 · Cited by 115
Probst, V., Allouis, M., Sacher, F., Pattier, S., Babuty, D., Mabo, P., Mansourati, J., Victor, J., Nguyen, J., Schott, J., et al. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00349.x · Cited by 114
Self-citationEmpiric quinidine therapy for asymptomatic Brugada syndrome: Time for a prospective registry
Viskin, S., Wilde, A., Tan, H. L., Antzelevitch, C., Shimizu, W., & Belhassen, B. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.11.030 · Cited by 114
Self-citationRosso, R., Click, A., Glikson, M., Wagshal, A., Swissa, M., Rosenhek, S., Shetboun, I., Khalamizer, V., Fuchs, T. T., Boulos, M., et al. (2008) · PubMed · Cited by 90
Rosso, R., Glick, A., Glikson, M., et al. (2008) · PubMed · Cited by 85
Effects of Low-Dose Quinidine on Ventricular Tachyarrhythmias in Patients With Brugada Syndrome
Mizusawa, Y., Sakurada, H., Nishizaki, M., & Hiraoka, M. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000206437.27854.65 · Cited by 74
Kontny, F., & DALE, J. (1990) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1990.tb00145.x · Cited by 50
Probst, V., Evain, S., Gournay, V., Allouis, M., Schott, J., Boisseau, P., & Marec, H. L. (2005) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2005.00329.x · Cited by 50
Self-citationWhen Our Best Is Not Enough: The Death of a Teenager with Brugada Syndrome
Brugada, P., Brugada, J., & Brugada, R. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01247.x · Cited by 12
Probst, V., Mabo, P., Sacher, F., Babuty, D., Mansourati, J., & Marec, H. L. (2009) · EP Europace · doi:10.1093/europace/eun365 · Cited by 11
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Metadata
- Authors
- Probst, V., Veltmann, C., Eckardt, L., Meregalli, P. G., Gaita, F., Tan, H. L., Babuty, D., Sacher, F., Giustetto, C., Schulze-Bahr, E., Borggrefe, M., Haissaguerre, M., Mabo, P., Le Marec, H., Wolpert, C., & Wilde, A. A. M.
- Affiliations
- Inserm (FR)
- From INSERM, UMR915, Nantes, France (V.P., H.L.M.); Université de Nantes, l’institut du thorax, Nantes, France (V.P., H.L.M.); CHU Nantes, l’institut du thorax, Service de cardiologie, Nantes, France (V.P., H.L.M.); First Department of Medicine, Cardiology, University Hospital Mannheim, Mannheim, Germany (C.V., M.B., C.W.); University Hospital of Muenster, Department of Cardiology and Angiology, Muenster, Germany (L.E., E.S.-B.); Department of Cardiology, Academic Medical Center, University of...
- ORCID
- Venue
- Circulation
- Published
- 2010-02-09
- Volume
- 121
- Issue
- 5
- Pages
- 635-643
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2128734390
- Cited by
- 847
- References
- 37
- Citations by year
- 2026: 19 · 2025: 35 · 2024: 42 · 2023: 38 · 2022: 45 · 2021: 46 · 2020: 50 · 2019: 45 · 2018: 55 · 2017: 73 · 2016: 64 · 2015: 60 · 2014: 39 · 2013: 70 · 2012: 75
- FWCI
- 50.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- Agence Nationale de la Recherche
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Centre Hospitalier Universitaire de Nantes
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Keywords
- Brugada syndrome, sudden cardiac death, long-term prognosis, asymptomatic patients, syncope, implantable cardioverter-defibrillator shocks, SCN5A mutation, family history of sudden cardiac death
- MeSH terms
- Adult, Death, Electrocardiography, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prognosis, Registries, Ventricular Fibrillation, Brugada Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
